Dhampur BioQ1 FY25

Dhampur Bio Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹146.28P/E: 38.0Market Cap: ₹971 CrSector: Agricultural Food & other Products

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4
  • The company expects a good sugarcane crop this season with higher yields, which should lead to increased crushing volumes and better sugar recovery (Page 17).
  • They anticipate augmenting yields by working closely with farmers, especially in central UP where yield potential is currently lower (40-50 tonnes/ha) compared to West UP (75-80 tonnes/ha) (Page 17).
  • Branded sales are targeted for growth as a strategic focus, aiming to increase volumes despite lower per-unit margins (~0.5%) compared to country liquor, which currently yields margins of ~18-20% (Pages 15-16).
  • Ethanol production and sales volumes are currently hampered due to restrictions and high maize prices but there is scope to utilize dual-feed capacity to improve production when input prices are favorable (Pages 10, 15).
  • Country liquor volumes have grown (~30% Q-o-Q), though pricing is government regulated limiting pricing power; further market expansion and quota purchases are planned (Page 12).
  • Overall, volume growth in sugar, branded sugar, country liquor, and ethanol is expected alongside better crop yields and potential easing of diversion/export policies (Pages 17, 8-9).

See what Dhampur Bio management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • No specific mention of new fundraising through debt or equity in the near term.
  • Long-term loans stood at Rs. 229.96 crores as of 30th June 2024; working capital loan was Rs. 162.08 crores.
  • Company repaid Rs. 18.45 crores worth of loans during the quarter.
  • Debt-equity ratio stands at 0.86 times, considered strong.
  • Management believes steady cash flows and interest subvention schemes will maintain a strong balance sheet.
  • CAPEX for FY '25 is guided at Rs. 95 crores (Rs. 35 crores for maintenance, Rs. 60 crores for multi-feed distillery conversion).
  • No mention of plans for fresh equity raising or significant new borrowings as of the call date.

See what Dhampur Bio management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Total CAPEX guidance for FY '25 is Rs. 95 crores.
  • Rs. 60 crores allocated for the grain-based distillery (multi-feedstock conversion under interest subvention scheme).
  • Rs. 35 crores planned for maintenance CAPEX.
  • Sugar sector CAPEX cycle is largely complete; going forward, only maintenance CAPEX expected, roughly a percentage of depreciation.
  • Grain-based distillery to be ready by mid-November 2024, with flexibility to use maize or rice based on price and availability.
  • No major greenfield maize-based distillery planned due to current high raw material prices; focus is on opportunistic usage of existing capacity.
  • Objective to optimize existing capacities for growth and value addition, including branded sales expansion.

Track Dhampur Bio — get its next earnings analysis in your feed

How does Dhampur Bio rank vs peers in Agricultural Food & other Products?

Pro feature
ThisDhampur Bio
Rev 4Mar 3

How does Dhampur Bio rank in Agricultural Food & other Products?

Compare Dhampur Bio against every Agricultural Food & other Products company (Q1 FY25) on revenue, margins and earnings-call signals.

View Agricultural Food & other Products leaderboard →

Others in Agricultural Food & other Products this season

  • M.V.K. Agro (Q2 FY27)

    For the quarter ended September 30, 2026, MVK Agro Food Product Ltd reported revenue from operations of ₹6,145.91 lakhs, up from ₹4,215.70 lakhs in the same…

  • Gokul Refoils (Q2 FY27)

    17,449.65 lakhs (approximately 16.4% growth) . Key results statement takeaways from Gokul Refoils and Solvent Ltd's Q2 FY27 results statement — and how it ranks

  • Patanjali Foods (Q2 FY27)

    11,322.58 crores, up 15.55% YoY. Key results statement takeaways from Patanjali Foods Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • GRM Overseas (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹452.6 Cr, up 22% YoY from ₹372.4 Cr in Q2 FY26 (Page 8) . Key investor presentation takeaways from GRM Overseas Ltd's Q2 FY27

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →